X

Trial Profile

ZALTRAP Special Drug Use Surveillance (Unresectable advanced and/or recurrent colorectal cancer)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aflibercept (Primary)
Indications Colorectal cancer
Focus Adverse reactions; Therapeutic Use
Acronyms ZALTRAP
Sponsors Sanofi K.K.

Most Recent Events

14 Sep 2021 According to UMIN , Date of closure to data entry is 29 Jan 2021, Date trial data considered complete 19 Mar 2021 and Date analysis concluded is 23 May 2021.
14 Sep 2021 Status changed from active, no longer recruiting to completed.
25 Sep 2020 Planned End Date changed from 16 May 2020 to 23 May 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com